Search hospitals > New York > New York
Columbia University Irving Medical Center
Claim this profileNew York, New York 10032
Global Leader in Cancer
Global Leader in Coronavirus
Conducts research for COVID-19
Conducts research for Tumors
Conducts research for Alzheimer's Disease
358 reported clinical trials
122 medical researchers
Summary
Columbia University Irving Medical Center is a medical facility located in New York, New York. This center is recognized for care of Cancer, Coronavirus, COVID-19, Tumors, Alzheimer's Disease and other specialties. Columbia University Irving Medical Center is involved with conducting 358 clinical trials across 550 conditions. There are 122 research doctors associated with this hospital, such as Richard Carvajal, MD, Luca Szalontay, MD, Mark N. Stein, and Ran Reshef, MD.Area of expertise
1Cancer
Global LeaderStage IV
BRAF positive
Stage III
2Coronavirus
Global LeaderSARS-CoV-2
NAT
non-NAT
Top PIs
Richard Carvajal, MDColumbia University Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical Protoco2 years of reported clinical research
Studies Solid Tumors
Studies Tumors
20 reported clinical trials
60 drugs studied
Luca Szalontay, MDNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center6 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
20 reported clinical trials
28 drugs studied
Mark N. SteinColumbia University Irving Medical Center1 year of reported clinical research
Expert in Prostate Cancer
Studies Cancer
18 reported clinical trials
33 drugs studied
Ran Reshef, MDColumbia University4 years of reported clinical research
Studies Leukemia
Studies Lymphoma
18 reported clinical trials
29 drugs studied
Clinical Trials running at Columbia University Irving Medical Center
Cancer
Breast Cancer
Non-Hodgkin's Lymphoma
Bladder Cancer
Cardiomyopathy
Multiple Myeloma
Plasma Cell Neoplasms
Follicular Lymphoma
Lymphoma
Amyloidosis
Abatacept
for Myocarditis
The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first occurrence of cardiovascular death, non-fatal sudden cardiac arrest, cardiogenic shock, significant ventricular arrythmias, significant bradyarrythmias, or incident heart failure.
Recruiting3 awards Phase 311 criteria
Needs Navigation
for Caregivers of Young Adults with Cancer
The overall aim of the study is to address unmet health-related social needs and reduce outcome disparities among AYA cancer survivors. Aim 1 aimed to refine a needs navigation model in partnership with expert consultants. Aim 2 and 3 will involve the deployment and pilot testing of the adapted needs navigation intervention among caregivers of younger AYAs with cancer.
Recruiting1 award N/A
Adaptive Radiation
for Anal Cancer
This is a 20 patient pilot study to examine the feasibility of dose-adapted radiation therapy for the treatment of locally advanced anal squamous cell cancer. The tumor and a patient's anatomy may change during radiation treatment and daily adaption of the radiation plan (i.e., a new daily plan based on the anatomy of the day) may help to maximize the dose to the tumor and minimize the radiation dose to the normal surrounding organs.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Columbia University Irving Medical Center?
Columbia University Irving Medical Center is a medical facility located in New York, New York. This center is recognized for care of Cancer, Coronavirus, COVID-19, Tumors, Alzheimer's Disease and other specialties. Columbia University Irving Medical Center is involved with conducting 358 clinical trials across 550 conditions. There are 122 research doctors associated with this hospital, such as Richard Carvajal, MD, Luca Szalontay, MD, Mark N. Stein, and Ran Reshef, MD.
Where is Columbia University Irving Medical Center located?
The Columbia University Irving Medical Center is located at West 168th Street and Broadway in the Washington Heights neighborhood of northern Manhattan. For public transportation, options include the 1, A, or C trains to the 168th Street station, or buses M-2, 3, 4, 5, or 100. If driving, the recommended route involves exiting towards the George Washington Bridge, onto Riverside Drive, then left onto West 165th Street, and right onto Fort Washington Avenue to reach the medical center's parking facility.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Columbia University Irving Medical Center, contact the Office for Billing Compliance at 212-342-3947 or email shsinsurance@cumc.columbia.edu. For insurance inquiries, visit the Insurance and Administration department at 100 Haven Avenue, Tower 2, 2nd Floor, or email shsinsurance@cumc.columbia.edu.
What insurance does Columbia University Irving Medical Center accept?
The Columbia University Irving Medical Center (CUIMC) accepts a broad spectrum of insurance plans, including both commercial and government options. For specific doctor-related insurance inquiries, patients should refer to the doctor's profile on the ColumbiaDoctors website or contact the practice directly via phone as listed under "Our Locations." NewYork-Presbyterian Hospital, affiliated with CUIMC, supports a variety of insurance plans such as Aetna, Blue Cross Blue Shield, Cigna, United Healthcare, among others. Patients are advised to confirm with their insurance company to ensure coverage.
What awards or recognition has Columbia University Irving Medical Center received?
Columbia University Irving Medical Center (CUIMC) is celebrated for its pioneering research and superior patient care. It has been acknowledged for significant medical milestones, including the first successful heart transplant in a child and the development of the Apgar score for newborn assessment. CUIMC's faculty have received top honors, including the Nobel Prize in Chemistry, underscoring its dedication to scientific excellence and innovation.